← Back to events
ActiveTech

FDA clears blood test to aid evaluation for Alzheimer's disease

What happened

The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.

Summary assembled by rule from the sources below

Why it's spreading

Timeline

  1. First appeared on Hacker NewsHacker News

Sources